Da

✏️ Editing: 1677547883.M709523P508150.aristoteles.x5servers.net,S=24099,W=24599:2,S

Envelope-to: rcruz@sapasequipment.com
Delivery-date: Mon, 27 Feb 2023 21:31:23 -0400
From: "Groos, Torsten" <torsten.groos@moldev.com>
To: "rcruz@sapasequipment.com" <rcruz@sapasequipment.com>
Subject: Organoid Services
Thread-Topic: Organoid Services
Thread-Index: AdlLEoK+KL8GoouTQJ+pBgPSjg90rw==
Date: Tue, 28 Feb 2023 01:30:35 +0000
Message-ID: 
 <PH0P222MB0548110EAD0FC2EA8B3F219E81AC9@PH0P222MB0548.NAMP222.PROD.OUTLOOK.COM>
Accept-Language: en-US
Content-Language: en-US
x-ms-exchange-antispam-messagedata-chunkcount: 1
x-ms-exchange-antispam-messagedata-0: 
 =?us-ascii?Q?mYTQ5765fWRyepUDO5krqswevEp8W/OXRoSUZO4BEsS+BIzrM2tG/I50VHDT?=
 =?us-ascii?Q?UFRMDWS76GpBIc0MnYr+me75tU3oXeJDsJNAWpxqu7SnBcgGv45Ew+mHjWM+?=
 =?us-ascii?Q?2N5D5nx2+wIOO4WkuHCOBAjx3n2lRgQ0AxP5J/PlHweRhaOPtF0YoJNb8srW?=
 =?us-ascii?Q?sJoWnLaecn/8gil1wr7hPmVqLMOiWVhtK6luYCexTu6nOjN4rSllsA76hi8a?=
 =?us-ascii?Q?CYmHnWikZFVzLscZXd7MeETExx5AP6m4IM9BSeZcl6K0q2oquSV+AUgD7wYy?=
 =?us-ascii?Q?oJXeolqU5tDL1biEJoqDFQhP403g8/c6xvfN9XHpO7jXBqjAm4ARCQ1609c0?=
 =?us-ascii?Q?xBSMRJnxELR4R4sb/PJXb2WXAHmL8Cm/NX1js8fRhVruf0DgHK4g6Ldr/acy?=
 =?us-ascii?Q?87H+52CRJyfl6cQ93wXrJ9SR9aMlDu7IAFOZum/ljSWfLvI5PqDP4Khew5VV?=
 =?us-ascii?Q?8qvPzV62234vNk50HweAeQYQ/AHSITFLqIa9kWJgekTPpTDvTumQ5+bMJnPn?=
 =?us-ascii?Q?tDjYBrcIlT6Ko5D7/tlNwHpoS5fR9CuqhJ1unb48R/JoTEvCwQ4IO6xbdvuW?=
 =?us-ascii?Q?+Jngd1UZP8GHHX/yCtmupJtwX4IxxFZ3aRer2a8Uq73VqpM91faarqrRrbT4?=
 =?us-ascii?Q?txLwhHmFbA2eiH2g432+PEoEZJCMl2CdpbPh5aUgMdnHYelqHPczM2ukBco9?=
 =?us-ascii?Q?duDfxG+v8+OeGBOhEw3QpF7BBTUM3bweFAN92A5J3jHvWVu+npGgVDoEaQSb?=
 =?us-ascii?Q?V54JM8/ImXYITwQ16BBOKV5V/tvrpyQwQpLa83GaeNb/WQRfyJwjyx2PqDrP?=
 =?us-ascii?Q?0oIkRlyMPkghwLSpDD6QeiXxUvh9+wTQUJ2fB9Rc6/wkjmCCCT3BLp7GjgLK?=
 =?us-ascii?Q?MJbiam3XhhgmQUSGZFSYIPUbDWTcsNbY9a4ewwGZ+Lm8isWMN1qaUO3J2LSO?=
 =?us-ascii?Q?jg86XmRY639HNVwR3BQZP5kMdzvHSAR0V9N6cO5HHXV88pwY9a6gIWBVOQh+?=
 =?us-ascii?Q?6kgSoUOtM/fKH20r4AyhNt/lxHPiSqmlMdNZN8+3E0qZa1hpS+J7hkeSWW7w?=
 =?us-ascii?Q?2Gr+PgtIlArueD7oGZpICWS63nHdxJxIFoz3coOY7mPIuP/3uEmsFCtsDvVp?=
 =?us-ascii?Q?YmWMwt1C9JMMH3Uy16vTy0O13m/epxEftMG4+HixmP9fx2P7iI4J/UqwymzA?=
 =?us-ascii?Q?OHK/ZT3fHZiuXhu3iXnKa7Jw0Nibc/ivv9prpiPMhjRcWyT+1Z7abIDA/t4P?=
 =?us-ascii?Q?0IvuDIGsSjX5cKhyjvZLvZ2Cgg0rNGAOlsnnyA5juEQ7DlnPXLA7YgzryFmL?=
 =?us-ascii?Q?E9JaV5G+CYuX0545Zdmb8KMO6NaSXENumqtq87ygivsyyIXpcFmAyH13y89x?=
 =?us-ascii?Q?lI/Ulw2XZQXMf5bmnyaqVapQhVWT4L0JBHL73TPTkTLKTYTFWJVTieWDgzv0?=
 =?us-ascii?Q?fYyt3CkFNgFfoAlS7erENTXdCfIKbelw4coFVdoMm49doAF8mq9ngVuuIQFM?=
 =?us-ascii?Q?PmJ0JI9J2Lgy5dYyAC1cbkagob/NJbic3u6cv4QDH7tQJqnUSOMpKUjfC++g?=
 =?us-ascii?Q?aipcN3aBhKNMUdOEt9Ou8myHuvF/QI6ubUeoFHlU/AeUEKqbQe+7wediJ/2l?=
 =?us-ascii?Q?gQ=3D=3D?=
Content-Type: multipart/alternative;
	boundary="_000_PH0P222MB0548110EAD0FC2EA8B3F219E81AC9PH0P222MB0548NAMP_"
MIME-Version: 1.0
X-MS-Exchange-AntiSpam-ExternalHop-MessageData-ChunkCount: 1
X-MS-Exchange-AntiSpam-ExternalHop-MessageData-0: 
	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
X-OriginatorOrg: moldev.com
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-AuthSource: PH0P222MB0548.NAMP222.PROD.OUTLOOK.COM
X-MS-Exchange-CrossTenant-Network-Message-Id: 6e5f5190-e99d-4d4e-7416-08db192b642d
X-MS-Exchange-CrossTenant-originalarrivaltime: 28 Feb 2023 01:30:35.7889
 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: 771c9c47-7f24-44dc-958e-34f8713a8394
X-MS-Exchange-CrossTenant-mailboxtype: HOSTED
X-MS-Exchange-CrossTenant-userprincipalname: dFp+GWtxnyFZgvcV2WYSw2FXyecAbv2rzCQ8FC6S/Gs3Ct17I0WBO97Gky4uNbi7tub8Bu9462Y+ShBG9dVvwHsUdGI2w5mzjbf85YwRDRk=
X-MS-Exchange-Transport-CrossTenantHeadersStamped: SA1P222MB0101
X-Proofpoint-ORIG-GUID: 9M4VnHEap9ie_GgEIzASbXTtJChLpwK6
X-Proofpoint-GUID: 9M4VnHEap9ie_GgEIzASbXTtJChLpwK6
X-Proofpoint-Virus-Version: vendor=baseguard
 engine=ICAP:2.0.219,Aquarius:18.0.930,Hydra:6.0.562,FMLib:17.11.170.22
 definitions=2023-02-27_19,2023-02-27_01,2023-02-09_01
X-Proofpoint-Spam-Details: rule=notspam policy=default score=0 adultscore=0 mlxscore=0 spamscore=0
 lowpriorityscore=0 impostorscore=0 priorityscore=1501 malwarescore=0
 mlxlogscore=320 clxscore=1015 suspectscore=0 phishscore=0 bulkscore=0
 classifier=spam adjust=0 reason=mlx scancount=1 engine=8.12.0-2212070000
 definitions=main-2302280009
X-Spam-Status: No, score=0.2
X-Spam-Score: 2
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "aristoteles.x5servers.net",
 has NOT identified this incoming email as spam. The original
 message has been attached to this so you can view it or label
 similar future email. If you have any questions, see
 root\@localhost for details.
 Content preview: Hi Richard, I would like to share the exciting news that with
 the recent acquisition of Cellesce<https://cellesce.com/>, Molecular Devices
 is now offering organoid services from "off the shelf" soluti [...] 
 Content analysis details: (0.2 points, 5.0 required)
 pts rule name description
 ---- ---------------------- --------------------------------------------------
 0.0 T_SPF_HELO_TEMPERROR SPF: test of HELO record failed (temperror)
 0.0 T_SPF_TEMPERROR SPF: test of record failed (temperror)
 0.0 HTML_MESSAGE BODY: HTML included in message
 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
 valid
 0.0 KAM_DMARC_STATUS Test Rule for DKIM or SPF Failure with Strict
 Alignment
 0.1 DKIM_INVALID DKIM or DK signature exists, but is not valid
X-Spam-Flag: NO

--_000_PH0P222MB0548110EAD0FC2EA8B3F219E81AC9PH0P222MB0548NAMP_
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

Hi Richard,
I would like to share the exciting news that with the recent acquisition of=
 Cellesce<https://cellesce.com/>, Molecular Devices is now offering organoi=
d services from "off the shelf" solutions to development of your own organo=
id line. Cellesce' s patented novel bioprocess ensures better reproducibili=
ty, consistency and scalability which hasn't been available to the market y=
et. Would you be interested to learn more about it?
I apologize if this is not relevant to your research and appreciate if you =
could share with your colleagues who might be interested.
I look forward to hearing from you!
Torsten
Torsten Groos
Drug Discovery Sales Representative
Phone: 1.214.449.4510
Email: torsten.groos@moldev.com <mailto:andrew.juszczak@moldev.com>
Tech Support: 1-800-635-5577

Please be advised that this email may contain confidential information. If =
you are not the intended recipient, please notify us by email by replying t=
o the sender and delete this message. The sender disclaims that the content=
 of this email constitutes an offer to enter into, or the acceptance of, an=
y agreement; provided that the foregoing does not invalidate the binding ef=
fect of any digital or other electronic reproduction of a manual signature =
that is included in any attachment.

--_000_PH0P222MB0548110EAD0FC2EA8B3F219E81AC9PH0P222MB0548NAMP_
Content-Type: text/html; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-micr=
osoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" xmlns=3D"http:=
//www.w3.org/TR/REC-html40">
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dus-ascii"=
>
<meta name=3D"Generator" content=3D"Microsoft Word 15 (filtered medium)">
<style></style>
</head>
<body lang=3D"EN-US" link=3D"#0563C1" vlink=3D"#954F72">
<div class=3D"WordSection1">
<o:p>&nbs=
p;</o:p>
Hi Richard,<o:p></o:p>
<a name=3D"_Hlk127455455">I would like t=
o share the exciting news that with the</a>
 recent acquisition of <a href=3D"https://cellesce.com/"><spa=
n style=3D"mso-bookmark:_Hlk127455455"><ins cite=3D"mailto:Groos,%2=
0Torsten">Cellesce</ins></a>,
 Molecular Devices is now offering organoid services from &#8220;off=
 the shelf&#8221; solutions to development of your own organoid line. Celle=
sce&#8217; s patented novel bioprocess ensures better reproducibility, cons=
istency and scalability which hasn&#8217;t been available
 to the market yet. Would you be interested to learn more about it?<o=
:p></o:p>
I apologize if this is not relevant to your research and appreciate if y=
ou could share with your colleagues who might be
 interested. <o:p></o:p>
I look forward to hearing from you!<o:p></o:p>
Torsten<o:p></o:p>

Torsten Groos
<o:p></o:p>
Drug Discovery Sales Representative 
Phone: 1.214.449.4510<spa=
n style=3D"font-size:9.0pt;line-height:105%;font-family:&quot;Arial&quot;,s=
ans-serif;color:#008DA8"> 
Email:
<a href=3D"mailto:andrew.juszczak@moldev.com">torsten=
.groos@moldev.com
</a> 
Tech Support: 1-800-635-5577<spa=
n style=3D"font-size:9.0pt;line-height:105%;font-family:&quot;Arial&quot;,s=
ans-serif;color:#008DA8"><o:p></o:p>
<o:p>&nbsp;</o:p>
<o:p>&nbsp;</o:p>
</div>
Please be advised that this email may contain confidential information. If =
you are not the intended recipient, please notify us by email by replying t=
o the sender and delete this message. The sender disclaims that the content=
 of this email constitutes an offer
 to enter into, or the acceptance of, any agreement; provided that the fore=
going does not invalidate the binding effect of any digital or other electr=
onic reproduction of a manual signature that is included in any attachment.
</body>
</html>

--_000_PH0P222MB0548110EAD0FC2EA8B3F219E81AC9PH0P222MB0548NAMP_--

📁 Sid Gifari File Manager